phenylmethylsulfonyl fluoride has been researched along with Coronary Disease in 1 studies
Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hülsmann, WC | 1 |
| Dubelaar, ML | 1 |
| Lamers, JM | 1 |
| Maccari, F | 1 |
1 other study available for phenylmethylsulfonyl fluoride and Coronary Disease
| Article | Year |
|---|---|
Protection by acyl-carnitines and phenylmethylsulfonyl fluoride of rat heart subjected to ischemia and reperfusion.
Topics: Animals; Calcium; Carnitine; Cell Membrane; Coronary Disease; Cytosol; Glycogen Synthase; L-Lactate | 1985 |